
### [NCIT:C40026](http://purl.obolibrary.org/obo/NCIT_C40026)
**Label:** Malignant Ovarian Epithelial Tumor

**Subclasses:** [NCIT:C5228](http://purl.obolibrary.org/obo/NCIT_C5228) (Ovarian Cystadenocarcinoma), [NCIT:C67092](http://purl.obolibrary.org/obo/NCIT_C67092) (Ovarian Serous Adenocarcinofibroma), [NCIT:C7700](http://purl.obolibrary.org/obo/NCIT_C7700) (Ovarian Adenocarcinoma), [NCIT:C105556](http://purl.obolibrary.org/obo/NCIT_C105556) (Low Grade Ovarian Serous Adenocarcinoma), [NCIT:C5243](http://purl.obolibrary.org/obo/NCIT_C5243) (Ovarian Mucinous Adenocarcinoma), [NCIT:C105555](http://purl.obolibrary.org/obo/NCIT_C105555) (High Grade Ovarian Serous Adenocarcinoma), [NCIT:C6256](http://purl.obolibrary.org/obo/NCIT_C6256) (Ovarian Serous Surface Papillary Adenocarcinoma), [NCIT:C4270](http://purl.obolibrary.org/obo/NCIT_C4270) (Malignant Ovarian Brenner Tumor), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), [NCIT:C5240](http://purl.obolibrary.org/obo/NCIT_C5240) (Ovarian Transitional Cell Carcinoma), [NCIT:C40025](http://purl.obolibrary.org/obo/NCIT_C40025) (Malignant Ovarian Serous Tumor), [NCIT:C40089](http://purl.obolibrary.org/obo/NCIT_C40089) (Malignant Ovarian Transitional Cell Tumor), [NCIT:C36102](http://purl.obolibrary.org/obo/NCIT_C36102) (Hereditary Ovarian Carcinoma), [NCIT:C9192](http://purl.obolibrary.org/obo/NCIT_C9192) (Ovarian Carcinosarcoma), [NCIT:C40440](http://purl.obolibrary.org/obo/NCIT_C40440) (Ovarian Small Cell Carcinoma, Pulmonary Type), [NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation), [NCIT:C7979](http://purl.obolibrary.org/obo/NCIT_C7979) (Ovarian Endometrioid Adenocarcinoma), [NCIT:C7978](http://purl.obolibrary.org/obo/NCIT_C7978) (Ovarian Serous Cystadenocarcinoma), [NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma), [NCIT:C5238](http://purl.obolibrary.org/obo/NCIT_C5238) (Ovarian Large Cell Neuroendocrine Carcinoma), [NCIT:C7833](http://purl.obolibrary.org/obo/NCIT_C7833) (Recurrent Ovarian Carcinoma), [NCIT:C7550](http://purl.obolibrary.org/obo/NCIT_C7550) (Ovarian Serous Adenocarcinoma), [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C40077](http://purl.obolibrary.org/obo/NCIT_C40077) (Malignant Ovarian Clear Cell Tumor), [NCIT:C40033](http://purl.obolibrary.org/obo/NCIT_C40033) (Malignant Ovarian Mucinous Tumor), [NCIT:C40051](http://purl.obolibrary.org/obo/NCIT_C40051) (Malignant Ovarian Endometrioid Tumor), [NCIT:C27390](http://purl.obolibrary.org/obo/NCIT_C27390) (Ovarian Small Cell Carcinoma), [NCIT:C4908](http://purl.obolibrary.org/obo/NCIT_C4908) (Ovarian Carcinoma), [NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma), [NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma), [NCIT:C4509](http://purl.obolibrary.org/obo/NCIT_C4509) (Undifferentiated Ovarian Carcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0004911](http://purl.obolibrary.org/obo/UBERON_0004911) (epithelium of female gonad) 54.17%
- [UBERON:0004909](http://purl.obolibrary.org/obo/UBERON_0004909) (epithelium of gonad) 54.17%
- [UBERON:0001304](http://purl.obolibrary.org/obo/UBERON_0001304) (germinal epithelium of ovary) 54.17%
- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 54.17%
- Thing 52.77%
- [UBERON:0003134](http://purl.obolibrary.org/obo/UBERON_0003134) (female reproductive organ) 33.03%
- [UBERON:0000992](http://purl.obolibrary.org/obo/UBERON_0000992) (ovary) 33.03%
- [UBERON:0000990](http://purl.obolibrary.org/obo/UBERON_0000990) (reproductive system) 33.03%
- [UBERON:0000991](http://purl.obolibrary.org/obo/UBERON_0000991) (gonad) and [UBERON:0003134](http://purl.obolibrary.org/obo/UBERON_0003134) (female reproductive organ) 33.03%
- [UBERON:0000992](http://purl.obolibrary.org/obo/UBERON_0000992) (ovary) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 33.03%
- [UBERON:0000992](http://purl.obolibrary.org/obo/UBERON_0000992) (ovary) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 33.03%
- [UBERON:0000992](http://purl.obolibrary.org/obo/UBERON_0000992) (ovary) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 33.03%
- [UBERON:0000992](http://purl.obolibrary.org/obo/UBERON_0000992) (ovary) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 33.03%
- [UBERON:0000992](http://purl.obolibrary.org/obo/UBERON_0000992) (ovary) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 33.03%
- [UBERON:0000992](http://purl.obolibrary.org/obo/UBERON_0000992) (ovary) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 33.03%


